100 Participants Needed

Behavioral Therapy for Tic Disorders

Recruiting at 1 trial location
ER
SW
Overseen BySonya Wang, MD
Age: < 18
Sex: Any
Trial Phase: Phase 2
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Tourette Syndrome and Persistent Motor/Vocal Tic Disorder affect 1-3% of youth and can be associated with impaired functioning, emotional and behavioral problems, physical pain, diminished quality of life, and peer victimization. Chronic tics are the primary symptom. Comprehensive Behavioral Intervention for Tics (CBIT) is a manualized treatment focused on tic management skills. During the core CBIT procedure, competing response training, patients learn to inhibit tics by engaging in a competing motor action. The overall objective of this study is to identify bio-behavioral predictors and correlates of response and the most potent aspects of CBIT. Participants with chronic tics will complete a manualized course of 8-session CBIT. Neural, behavioral, psychosocial, and global functioning will be assessed longitudinally to examine predictors and correlates of response. CBIT sessions will be video recorded. CBIT process will be measured with a video-based behavioral coding scheme that will be refined and validated during years 1-2 using archival CBIT videos

Will I have to stop taking my current medications?

If you are taking psychotropic medications, you can continue them as long as they have been stable for at least 6 weeks and remain stable during the study. All treatments will be monitored, but the protocol does not specify stopping current medications.

What data supports the effectiveness of the treatment Comprehensive Behavioral Intervention for Tics (CBIT) and Habit Reversal Therapy (HRT) for tic disorders?

Research shows that CBIT and HRT, which are types of behavioral therapy, can significantly reduce tic symptoms in people with tic disorders, including Tourette syndrome. Studies found that these therapies can decrease tic severity by 18.3% to 37.5%, making them effective alternatives to medication.12345

Is behavioral therapy for tic disorders safe for humans?

Comprehensive Behavioral Intervention for Tics (CBIT) and Habit Reversal Training (HRT) are considered safe treatments for managing tics in conditions like Tourette syndrome, with studies showing they are well-tolerated and effective without the serious side effects often associated with medications.13567

How is the treatment Comprehensive Behavioral Intervention for Tics (CBIT) different from other treatments for tic disorders?

CBIT, also known as Habit Reversal Therapy (HRT), is unique because it is a non-drug treatment that uses behavioral techniques to help reduce tic symptoms, offering an effective alternative or complement to medication, which can have unpredictable effects and serious side effects.12458

Research Team

DG

Deanna Greene, PhD

Principal Investigator

University of California, San Diego

SW

Sonya Wang, MD

Principal Investigator

University of Minnesota

CC

Christine Conelea, PhD, LP

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for young people with tic disorders, including Tourette Syndrome and Chronic Tic Disorder. Participants should be experiencing chronic tics that impact their daily life. The study aims to help them manage their symptoms through a treatment called CBIT.

Inclusion Criteria

I am between 10 and 17 years old.
I have had motor or vocal tics for over a year without a break longer than 3 months.
Full scale IQ greater than 70
See 2 more

Exclusion Criteria

I haven't changed my mental health medication in the last 6 weeks and don't plan to change it during the study.
I have a history of seizures.
I have attended at least 4 CBIT sessions.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants complete a manualized course of 8-session Comprehensive Behavioral Intervention for Tics (CBIT)

8 weeks
8 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

19 weeks

Treatment Details

Interventions

  • Comprehensive Behavioral Intervention for Tics (CBIT)
Trial OverviewThe trial tests Comprehensive Behavioral Intervention for Tics (CBIT), which teaches patients how to control tics using competing motor actions. It involves an 8-session course where the effectiveness of CBIT will be evaluated through various assessments and video recordings.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: CBIT groupExperimental Treatment1 Intervention
Participants with chronic TICs

Comprehensive Behavioral Intervention for Tics (CBIT) is already approved in United States, European Union, Canada for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Comprehensive Behavioral Intervention for Tics for:
  • Tourette Syndrome
  • Persistent Motor/Vocal Tic Disorder
πŸ‡ͺπŸ‡Ί
Approved in European Union as Comprehensive Behavioral Intervention for Tics for:
  • Tourette Syndrome
  • Tic Disorders
πŸ‡¨πŸ‡¦
Approved in Canada as Comprehensive Behavioral Intervention for Tics for:
  • Tourette Syndrome
  • Tic Disorders

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

A meta-analysis of 10 randomized controlled trials involving 586 patients found that habit reversal training (HRT) is effective in reducing tic symptoms, with a small to medium effect size (SMD of -0.43).
The efficacy of HRT was influenced by the type of behavioral therapy used in the control group, indicating that different comparison conditions can affect treatment outcomes.
The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials.Yu, L., Li, Y., Zhang, J., et al.[2021]
Habit reversal therapy (HRT) has been shown to significantly reduce tic severity in individuals with Tourette syndrome and chronic tic disorders, with reductions ranging from 18.3% to 37.5% across five studies involving 353 patients.
The evidence supports HRT as an effective alternative or complement to medication for managing tics, but more research is needed to compare its efficacy against other behavioral interventions.
The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review.Dutta, N., Cavanna, AE.[2022]
Comprehensive behavioral intervention for tics (CBIT) is a safe and effective treatment for Tourette syndrome, supported by evidence from two large multisite trials that demonstrate its efficacy and long-term benefits.
Recent guidelines recommend CBIT as a first-line treatment for tic disorders, indicating its importance in managing tics compared to traditional medications, and there is a growing effort to train more providers in the U.S. to deliver this intervention.
Current controversies on the role of behavior therapy in Tourette syndrome.Scahill, L., Woods, DW., Himle, MB., et al.[2021]

References

The therapeutic effect of habit reversal training for Tourette syndrome: a meta-analysis of randomized control trials. [2021]
The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. [2022]
Current controversies on the role of behavior therapy in Tourette syndrome. [2021]
Behavioural treatment of tics: habit reversal and exposure with response prevention. [2022]
Habit reversal training for tic disorders in children and adolescents. [2007]
Pilot Testing Behavior Therapy for Chronic Tic Disorders in Neurology and Developmental Pediatrics Clinics. [2016]
Group behavioral interventions for tics and comorbid symptoms in children with chronic tic disorders. [2022]
Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research. [2022]